首页> 外文OA文献 >MEASUREMENT OF CONTROLLED ATTENUATION PARAMETER: A SURROGATE MARKER OF HEPATIC STEATOSIS IN PATIENTS OF NONALCOHOLIC FATTY LIVER DISEASE ON LIFESTYLE MODIFICATION - A PROSPECTIVE FOLLOW-UP STUDY
【2h】

MEASUREMENT OF CONTROLLED ATTENUATION PARAMETER: A SURROGATE MARKER OF HEPATIC STEATOSIS IN PATIENTS OF NONALCOHOLIC FATTY LIVER DISEASE ON LIFESTYLE MODIFICATION - A PROSPECTIVE FOLLOW-UP STUDY

机译:受控衰减参数测量参数:在生活方式修饰中非酒精性脂肪肝疾病患者肝硬化的替代标志性 - 一种前瞻性后续研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

ABSTRACT BACKGROUND: Liver biopsy is a gold standard method for hepatic steatosis assessment. However, liver biopsy is an invasive and painful procedure and can cause severe complications therefore it cannot be frequently used in case of follow-up of patients. Non-invasive assessment of steatosis and fibrosis is of growing relevance in non-alcoholic fatty liver disease (NAFLD). To evaluate hepatic steatosis, transient elastography with controlled attenuation parameter (CAP) measurement is an option now days. OBJECTIVE: Aim of this study is to evaluate role of measurement of controlled attenuation parameter, a surrogate marker of hepatic steatosis in patients of nonalcoholic fatty liver disease on lifestyle modification. METHODS: In this study, initially 37 participants were included who were followed up after 6 months with transient elastography, blood biochemical tests and anthropometric measurements. The results were analyzed by Multivariate linear regression analysis and paired samples t-test (Dependent t-test) with 95% confidence interval. Correlation is calculated by Pearson correlation coefficients. RESULTS: Mean CAP value for assessing hepatic steatosis during 1st consultation (278.57±49.13 dB/m) was significantly improved (P=0.03) after 6 months of lifestyle modification (252.91±62.02 dB/m). Only fasting blood sugar (P=0.008), weight (P=0.000), body mass index (BMI) (P=0.000) showed significant positive correlation with CAP. Only BMI (P=0.034) and weight (P=0.035) were the independent predictor of CAP value in NAFLD patients. CONCLUSION: Lifestyle modification improves the hepatic steatosis, and CAP can be used to detect the improvement of hepatic steatosis during follow-up in patients with NAFLD on lifestyle modification. There is no relation between CAP and Fibroscan score in NAFLD patients. Only BMI and weight can predict CAP value independently.
机译:摘要背景:肝活检是一种用于肝脏脂肪变性评估的金标准方法。然而,肝脏活组织检查是一种侵入性和痛苦的程序,因此可能导致严重的并发症,因此在患者随访时不能经常使用。无侵袭性评估脂肪变性和纤维化是在非酒精脂肪肝病(NAFLD)中的相关性。为了评估肝脏脂肪变性,具有受控衰减参数(帽)测量的瞬态弹性术是现在的选择。目的:本研究的目的是评估对受控衰减参数的测量的作用,非酒精性脂肪肝疾病患者的肝硬化蛋白脂肪变性的替代标志物。方法:在这项研究中,最初包含37名参与者,随访6个月后瞬态弹性术,血液生化试验和人体测量测量。通过多变量线性回归分析和配对样品T检验(依赖性T检验)分析结果,具有95%置信区间。 Pearson相关系数计算相关性。结果:在生活方式改性6个月后,在第一个咨询(278.57±49.13dB / m)中,平均评估肝脏脂肪变性(278.57±49.13 dB / m)(252.91±62.02 dB / m)。只有禁食血糖(P = 0.008),重量(P = 0.000),体质量指数(BMI)(P = 0.000)显示出与帽的显着正相关。只有BMI(P = 0.034)和重量(P = 0.035)是NAFLD患者帽值的独立预测因子。结论:生活方式改善改善了肝脏脂肪变性,帽可用于检测NAFLD在生活方式改性患者随后的肝脏脂肪变性的改善。 NAFLD患者的帽和纤维血管得分无关。只有BMI和重量可以独立地预测盖卡值。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号